Home | Screening data | Screen comparisons | Search for compounds | Structure search

Compound InformationSONAR Target prediction
Name:

BUDESONIDE

Unique Identifier:SPE01500813
MolClass: Checkout models in ver1.5 and ver1.0
Molecular Formula:
Molecular Weight:396.264 g/mol
X log p:3.817  (online calculus)
Lipinksi Failures0
TPSA52.6
Hydrogen Bond Donor Count:0
Hydrogen Bond Acceptors Count:6
Rotatable Bond Count:4
Canonical Smiles:CCCC1OC2CC3C4CCC5=CC(=O)C=CC5(C)C4C(O)CC3(C)C2(O1)C(=O)CO
Source:semisynthetic
Therapeutics:antiinflammatory
Generic_name:Budesonide
Drug_type:Approved Drug
Pharmgkb_id:PA448681
Kegg_compound_id:C06858
Drugbank_id:APRD00442
Melting_point:221-232 oC
H2o_solubility:insoluble
Logp:3.145
Cas_registry_number:51333-22-3
Drug_category:Bronchodilator Agents; Anti-inflammatory Agents; Corticosteroids; ATC:A07EA06;
ATC:D07AC09; ATC:R01AD05; ATC:R03BA02
Indication:For the treatment of mild to moderate active Crohn-s disease.
Pharmacology:Budesonide is a synthetic corticosteroid indicated for the treatment of mild to
moderate active Crohn-s disease involving the ileum and/or the ascending colon.
Budesonide is used in Crohn-s disease to decrease the symptoms and inflammation
associated with the disease, especially at times of flare up. Budesonide has a high
topical glucocorticosteroid (GCS) activity and a substantial first pass elimination.
The formulation contains granules which are coated to protect dissolution in gastric
juice, but which dissolve at pH >5.5, ie, normally when the granules reach the
duodenum. Thereafter, a matrix of ethylcellulose with budesonide controls the
release of the drug into the intestinal lumen in a time-dependent manner.
Mechanism_of_action:The exact mechanism of action of budesonide in the treatment of Crohn-s disease is
not fully understood. However, being a glucocorticosteroid, budesonide has a high
local anti-inflammatory effect.
Organisms_affected:Humans and other mammals

Found: 205 nonactive as graph: single | with analogs [1] << Back 1 2 3 4 5 6 7 8 9 10  Next >> [205]
Species: 4932
Condition: BY4743
Replicates: 2
Raw OD Value: r im 0.9940±0
Normalized OD Score: sc h 1.0000±0
Z-Score: 1.2198±0
p-Value: 0.222526
Z-Factor: -26.3327
Fitness Defect: 1.5027
Bioactivity Statement: Nonactive
Experimental Conditions
Library:Spectrum_ED
Plate Number and Position:5|H9
Drug Concentration:50.00 nM
OD Absorbance:595 nm
Robot Temperature:30.00 Celcius
Date:2012-05-28 YYYY-MM-DD
Plate CH Control (+):0.0985±0.00995
Plate DMSO Control (-):0.976±0.01594
Plate Z-Factor:0.9115
png
ps
pdf

DBLink | Rows returned: 132 3 Next >> 
2462
40000
63006
470826
3033890
5281004

internal high similarity DBLink | Rows returned: 1
LOPAC 00729 1.0000

nonactive | Cluster 17014 | Additional Members: 17 | Rows returned: 142 3 Next >> 
SPE01505125 0.577319587628866
Prest1079 0.577319587628866
Prest1284 0.454545454545455
LOPAC 00729 0.425287356321839
Prest840 0.425287356321839
LAT003F07 0.425287356321839

Service provided by the Mike Tyers Laboratory